reSee.it Podcast Summary
Megyn Kelly opens the show discussing the media's reaction to President-elect Donald Trump’s upcoming inauguration, highlighting various emotional responses from figures like Don Lemon and Jeff Bezos. The conversation shifts to breaking news about mysterious drone sightings reported by Maryland Governor Larry Hogan, who expressed public concern over the lack of transparency from federal authorities regarding these incidents. Despite government assurances that the drones do not pose a threat, lawmakers are demanding briefings to clarify the situation.
Hugh Hewitt joins the discussion, expressing skepticism about the federal government's dismissive stance on the drone sightings. He mentions that experts, including Shy Sankar from Palantir, find the situation alarming, emphasizing the need for better control over airspace. The conversation touches on the possibility of foreign adversaries exploiting gaps in U.S. security.
The dialogue then transitions to Pete Hegseth, whose West Point admission is questioned by ProPublica. Hegseth's acceptance letter is presented as evidence against claims that he lied about his admission. Hewitt criticizes ProPublica for their rushed reporting and lack of journalistic integrity, suggesting that the scrutiny Hegseth faces is politically motivated.
Kelly and Hewitt also discuss the media's treatment of Trump and the frustrations of reporters covering his transition team, noting the differences in access compared to previous elections. They highlight the challenges faced by journalists trying to report on Trump’s administration.
The conversation shifts to Dr. Aseem Malhotra, who discusses his documentary, "First Do No Harm," which critiques the pharmaceutical industry's influence on healthcare, particularly regarding statins and cholesterol. Malhotra argues that high LDL cholesterol is not a significant risk factor for heart disease and emphasizes the importance of addressing insulin resistance and lifestyle changes for heart health. He shares patient success stories and stresses the need for independent evaluation of drug trials.
Malhotra also addresses the psychological barriers preventing acknowledgment of vaccine-related health issues, particularly concerning mRNA vaccines. He highlights the need for improved metabolic health and lifestyle changes to mitigate potential vaccine side effects. The discussion concludes with a call for transparency and accountability in the pharmaceutical industry and healthcare practices.